BIOSCIBD.COM
BioSci BDBioSci BD is a growing collection of articles, analyses and presentations on alliance trends, evolving deal terms, and the biofinancing industry.
http://www.bioscibd.com/
BioSci BD is a growing collection of articles, analyses and presentations on alliance trends, evolving deal terms, and the biofinancing industry.
http://www.bioscibd.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
3.6 seconds
16x16
32x32
WHOISGUARD, INC.
WHOISGUARD PROTECTED
P.O. B●●●●●●-03411
PA●●MA , PANAMA, NA
PA
View this contact
WHOISGUARD, INC.
WHOISGUARD PROTECTED
P.O. B●●●●●●-03411
PA●●MA , PANAMA, NA
PA
View this contact
WHOISGUARD, INC.
WHOISGUARD PROTECTED
P.O. B●●●●●●-03411
PA●●MA , PANAMA, NA
PA
View this contact
BUY YOUR DOMAIN
12
YEARS
7
MONTHS
18
DAYS
ENOM, INC.
WHOIS : whois.enom.com
REFERRED : http://www.enom.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
18
SITE IP
104.236.162.48
LOAD TIME
3.649 sec
SCORE
6.2
BioSci BD | bioscibd.com Reviews
https://bioscibd.com
BioSci BD is a growing collection of articles, analyses and presentations on alliance trends, evolving deal terms, and the biofinancing industry.
bioscibd.com
Alliance Trends | BioSci BD
https://bioscibd.com/trends
What is industry custom and practice for particular deal types and specific contract provisions? Mar 23, 2016. Trends in University Licenses How Healthy is the Seed Corn? Feb 15, 2016. Duration of Royalty Obligations ’Til Death Do Us Part? Oct 23, 2015. Sales Milestones Bridging the Valuation Gap. Nov 21, 2014.
Sell-Side Analysis | BioSci BD
https://bioscibd.com/sell-side
What do we really know about financial analysts' coverage of the biopharma industry? Biotech Sell Side Research A Retrospective Analysis. Jan 24, 2013.
2014 Year in Review | BioSci BD
https://bioscibd.com/2014-year-review
2014 Year in Review. IPOs, Financings and Alliances. Jan 5, 2015. 2014 was THE year of the Biotech IPO! 82 companies raised an aggregate of $5.7 billion in US IPO proceeds.
Demand Dividend | BioSci BD
https://bioscibd.com/demand-dividend
A New Investment Vehicle for Financing Biotech Companies. Feb 11, 2013. For nearly a decade we’ve been hearing about the need for a new financing model for biotech start-ups. It's high-time one was introduced. More ominously, late round investors in biotechs that went public in 2005-06 achieved IRRs that were nearly twice as high as IRRs of early round investors (30-34% versus 16-18%). This inversion of the risk/return tradeoff for staged investments in biotech start-ups was the first since the indus...
Sales Milestones | BioSci BD
https://bioscibd.com/bridging-the-valuation-gap
Bridging the Valuation Gap. Nov 21, 2014. The amount of potential sales milestone payments in biopharma alliances has increased substantially in the past decade. Become the bridge that closes the gap. Given this trend, and the time of year, it’s fair to ask How do I use this data to close the gap in. What does this tell us? More useful, however, is an appreciation of the specific sales milestone terms and trends exhibited by particular pharmaceutical companies across multiple alliances and over time....
TOTAL PAGES IN THIS WEBSITE
7
About | Bioscience Advisors
http://www.biosciadvisors.com/about
From 2008 through 2010, Mr. Edwards was the managing director of Deloitte Recap LLC, a wholly-owned subsidiary of Deloitte LLP. In this capacity, he ran Deloitte Recap and consulted on behalf of Deloitte on a variety of client engagements. In January 2011, Mr. Edwards founded Bioscience Advisors, Inc. (Biosci), a consulting and database firm focused on biopharma alliances. Biosci has created a database, BiosciDB. Biosci also launched a public discussion forum, BiosciBD.
TOTAL LINKS TO THIS WEBSITE
18
BiosciAbstracts - Gateway to abstracts for biomedical and life science conferences
Services to the medical and scientific world. You are here: Home. Is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences. More information. Provides searchable abstracts of presentations at key conferences in endocrinology. It is also a permanent, citable record, freely available to all without access restrictions. Don't see a title that covers your field? Contact us to learn more.
Registrant WHOIS contact information verification | Namecheap.com
You have reached a domain that is pending ICANN verification. As of January 1, 2014 the Internet Corporation for Assigned Names and Numbers (ICANN) will mandate that all ICANN accredited registrars begin verifying the Registrant WHOIS contact information for all new domain registrations and Registrant contact modifications. Why this domain has been suspended. Email address has not been verified. This is a new domain registration and the Registrant email address has not been verified. Wenn Sie Inhaber der...
Bioscience Advisors
Go to Discussion Forum. Bioscience Advisors, Inc. (Biosci) was founded in January 2011 as a consulting and database firm focused on biopharma alliances. Biosci's founder, Mark Edwards, has been involved in negotiating and analyzing biopharma alliances since the early days of the biotechnology era in the mid-1980s.
BiosciAlliance | Logon
Join or Register Society. You are here: Logon. Manage your combined profile and communicate with fellow scientists, clinicians and nurses. These are the core principles of the BiosciAlliance. Forgotten your password or membership number? Which other Society would you like to see in BiosciAlliance?
Bioscib
OLIO DI OLIVA (0). Fichi d'india (2). Fiori di ficodindia (1). Paste di Mandorle Siciliane. Termini e condizioni d'uso. Like us on Facebook. Follow us on Twitter.
BioSci BD
Sharing the Wealth Recent Trends in Biopharma Sublicensing. Feb 18, 2018. The Best Biotech IPO Window .That Money Can Buy! Jan 1, 2018. Changing the Deal How Far Can You Go and How Often. Oct 12, 2017. Dawn of a Post-Venture Era: The New Face of Innovation and Translational Research. Jun 25, 2017. Effective Royalty Rates in Biopharma Alliances What They Are and Why Use Them in Negotiations. Mar 25, 2017. Yours, Mine and Ours Partnering Compounds Globally. Oct 30, 2016. Jun 4, 2016. Mar 23, 2016.
BioSciBlog | A blog on all things bioscience..
A blog on all things bioscience. Skip to primary content. Skip to secondary content. Open access initiative reveals drug hits for deadly neglected tropical diseases. November 14, 2012. DNDi screens MMV’s open access Malaria Box, leading to three potential drug classes to treat sleeping sickness and leishmaniasis, which threaten the lives of millions throughout sub-Saharan Africa and pockets around the world. The open access Malaria Box. DNDi has helped establish three clinical research platforms: Leishma...
This site is temporarily unavailable
Powerful Web Hosting and Domain Names for Home and Business. Click here to chat with a live specialist. This site is temporarily unavailable. If you are the owner of this site, please contact customer support. Follow us on Twitter.
Home | Hormone - Related Cancer
Skip to main content. European Journal of Endocrinology. Journal of Molecular Endocrinology. Echo Research and Practice. Endocrinology, Diabetes and Metabolism Case Reports. Welcome to the Bioscientifica cancer site! Welcome to the first Bioscientifica topic-specific minisite, Hormone-Related Cancer! The site features articles on all aspects of cancer published in Bioscientifica's journals, from basic and translational research to clinical studies and case reports. Celebrating Women in Cancer Research:.
BioScience Communications
Individual Attention, Exceptional Results. Trusted partners to global clients in the healthcare industry—shaping communications strategy, engaging experts, analyzing and translating science, and executing effective initiatives across multiple media and disciplines. Following our proprietary methods, BioScience helps clients formulate and pressure-test the core narrative and scientific messages that drive consistent and compelling communications. Publication Planning and Execution. Expert roundtables....
